NCT03196466View on ClinicalTrials.gov

Population Pharmacokinetics of Antiepileptic in Pediatrics

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

June 19, 2017

Primary Completion Date

June 19, 2026

Study Completion Date

June 19, 2026

Conditions
Epilepsy
Interventions
BIOLOGICAL

Valproic acid

titration

BIOLOGICAL

carbamazepine

titration

BIOLOGICAL

phenobarbital

titration

BIOLOGICAL

phenytoin

titration

BIOLOGICAL

levetiracetam

titration

BIOLOGICAL

lamotrigine

titration

BIOLOGICAL

topiramate

titration

BIOLOGICAL

oxcarbazepine

titration

BIOLOGICAL

stiripentol

titration

BIOLOGICAL

clobazam

titration

BIOLOGICAL

brivaracétam

titration

BIOLOGICAL

felbamate

titration

BIOLOGICAL

lacosamide

titration

BIOLOGICAL

rufinamide

titration

BIOLOGICAL

gabapentine

titration

BIOLOGICAL

pregabaline

titration

BIOLOGICAL

sultiame

titration

BIOLOGICAL

tiagabine

titration

BIOLOGICAL

vigabatrine

titration

BIOLOGICAL

mesuximide

titration

BIOLOGICAL

primidone

titration

BIOLOGICAL

perampanel

titration

BIOLOGICAL

ethosuximide

titration

BIOLOGICAL

zonisamide

titration

BIOLOGICAL

cannabidiol

titration

OTHER

genetic polymorphisms

genetic polymorphisms

Trial Locations (1)

75014

RECRUITING

AP-HP Cochin, Paris

All Listed Sponsors
collaborator

URC-CIC Paris Descartes Necker Cochin

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT03196466 - Population Pharmacokinetics of Antiepileptic in Pediatrics | Biotech Hunter | Biotech Hunter